forecast
GLP-1 Class Could Exceed $100B Revenue
GLP-1 medicines will easily be in excess of $100 billion a year in revenue, and their adoption has exceeded almost everyone's expectations, including the speaker's own.
forecastpending
Speaker
AlexEvidence Quote
“this as a class of medicines will easily be in excess of $100 billion a year in revenue”
Source
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the BestCreated: 11/14/2026, 4:24:39 AM
Your notes
Loading notes...